Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Amwill Health CareBOM:544353 +0.56%42 PE Ratio (TTM) is 7.57 as of Aug. 04, 2026, which is 3% below its 10-year median of 7.77. GuruFocus rates BOM:544353 with a GF Score™ of 42/100. The stock has 3 warning signs investors should review. Among 87 Medical Distribution companies, Amwill Health Care ranks better than 89.66% on this metric.
The PE Ratio (TTM), or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). As of today (2026-08-04), Amwill Health Care's share price is
₹43.24.
Amwill Health Care's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹5.71. Therefore, Amwill Health Care's PE Ratio (TTM) for today is 7.57.
The historical rank and industry rank for Amwill Health Care's PE Ratio (TTM) or its related term are showing as below:
BOM:544353'
s PE Ratio (TTM) Range Over the Past 10 Years
Min: 4.59 Med: 7.77 Max: 15.75
Current: 7.49
During the past 6 years, the highest PE Ratio (TTM) of Amwill Health Care was 15.75. The lowest was 4.59. And the median was 7.77.
BOM:544353's PE Ratio (TTM) is ranked better than 89.66% of 87
companies
in the Medical Distribution industry
Industry Median: 15.97
vs BOM:544353: 7.49
During the past 6 years, Amwill Health Care's highest 3-Year average EPS without NRI Growth Rate was 59.60% per year. The lowest was 42.20% per year. And the median was 50.90% per year.
Amwill Health Care's EPS (Basic) for the
six
months ended in Mar. 2026 was ₹3.77.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹5.71.
Amwill Health Care (BOM:544353) PE Ratio (TTM) Explanation
The PE Ratio (TTM) can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio (TTM) is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.
In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio (TTM) is positive. Also for stocks with the same PE Ratio (TTM), the one with faster growth business is more attractive.
If a company loses money, the PE Ratio (TTM) becomes meaningless.
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio (TTM) divided by the growth ratio. He thinks a company with a PE Ratio (TTM) equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio (TTM) of 20, instead of a company growing 10% a year with a PE Ratio (TTM) of 10.
Because the PE Ratio (TTM) measures how long it takes to earn back the price you pay, the PE Ratio (TTM) can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.
Investors need to be aware that the PE Ratio (TTM) can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratio (TTM)s are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio (TTM) is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio .
PE Ratio (TTM) can also be affected by non-recurring-items such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio (TTM).
Amwill Health Care PE Ratio (TTM) Related Terms
Amwill Health Care PE Ratio (TTM) Historical Data
* Premium members only.
The historical data trend for Amwill Health Care's PE Ratio (TTM) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:544353 vs MCK, COR, CAH: PE Ratio (TTM) Comparison
For the Medical Distribution subindustry, Amwill Health Care's PE Ratio (TTM), along with its competitors' market caps and PE Ratio (TTM) data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Amwill Health Care PE Ratio (TTM) vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Amwill Health Care's PE Ratio (TTM) distribution charts can be found below:
* The bar in red indicates where Amwill Health Care's PE Ratio (TTM) falls into.
The PE Ratio (TTM), or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). It is the most widely used ratio in the valuation of stocks.
Amwill Health Care's Share Price of today is ₹43.24.
For company reported semi-annually, Amwill Health Care's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹5.71.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
There are at least three kinds of PE Ratio (TTM)s used by different investors. They are Trailing Twelve Month PE Ratio (TTM) or PE Ratio (TTM) (TTM), Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio (TTM) based on inflation-adjusted normalized PE Ratio (TTM) is called Shiller PE Ratio, after Yale professor Robert Shiller.
In the calculation of PE Ratio (TTM), the earnings per share used are the earnings per share over the past 12 months. For Forward PE Ratio, the earnings are the expected earnings for the next twelve months. In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.
For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.
Amwill Health Care (BOM:544353) has a PE Ratio (TTM) of 7.57 as of Aug. 04, 2026. Trailing 12-month P/E ratio is the ratio of share price to a company's trailing 12-month earnings per share. View historical data on Amwill Health Care and its competitors. This is near median its historical median of 7.77. Over the past decade, Amwill Health Care's PE Ratio (TTM) has ranged from 4.59 to 15.75. According to the industry distribution chart, Amwill Health Care ranks #9 out of 87 companies in the Medical Distribution industry, placing it in the top 10.3%.
Is Amwill Health Care's PE Ratio (TTM) too high?
Amwill Health Care's current PE Ratio (TTM) of 7.57 is near median its 10-year median of 7.77. Over the past 10 years, this metric has ranged from a low of 4.59 to a high of 15.75. The Medical Distribution industry median PE Ratio (TTM) is 15.97. Amwill Health Care's value of 7.57 is 52.6% below this industry median. Based on the distribution chart, Amwill Health Care ranks #9 out of 87 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Amwill Health Care has a GF Score™ of 42/100, reflecting its overall financial health beyond just this single metric.
How does Amwill Health Care's PE Ratio (TTM) compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Amwill Health Care ranks #9 out of 87 companies for PE Ratio (TTM). This places Amwill Health Care in the top 10% of its industry — outperforming the majority of peers. The industry median PE Ratio (TTM) is 15.97. Amwill Health Care's value of 7.57 is 52.6% below this benchmark. Historically, Amwill Health Care's own PE Ratio (TTM) has ranged from 4.59 to 15.75 over the past decade. While the company's 10-year median is 7.77 vs. the industry median of 15.97, Amwill Health Care has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PE Ratio (TTM) for a Medical Distribution company?
The median PE Ratio (TTM) among Medical Distribution companies is 15.97, based on 87 companies in the industry. Companies in the top quartile (top 25%) have a PE Ratio (TTM) significantly above this median, while those in the bottom quartile fall well below. However, PE Ratio (TTM) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Amwill Health Care's current PE Ratio (TTM) of 7.57 is 52.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PE Ratio (TTM) mean?
A high PE Ratio (TTM) can signal that a stock is expensive relative to its fundamentals. Trailing 12-month P/E ratio is the ratio of share price to a company's trailing 12-month earnings per share. View historical data on Amwill Health Care and its competitors. For the Medical Distribution industry, the median PE Ratio (TTM) is 15.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Amwill Health Care's current PE Ratio (TTM) is 7.57, which is near median its own 10-year median of 7.77. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Amwill Health Care stock overvalued right now?
Amwill Health Care (BOM:544353) has a current PE Ratio (TTM) of 7.57. The current PE Ratio (TTM) is 7.57, which is near median its 10-year median of 7.77 and 52.6% below the Medical Distribution industry median of 15.97. Amwill Health Care's overall GF Score™ is 42/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PE Ratio (TTM) calculated?
PE Ratio (TTM) is calculated from a company's financial statements. For Amwill Health Care (BOM:544353), the current PE Ratio (TTM) is 7.57 as of Aug. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Amwill Health Care Ltd is a derma-cosmetic development company. Its focus is on development of problem solving dermatological, cosmeceutical and aesthetical products. The product portfolio is divided into two categories, namely, development and contract manufacturing of generic dermatological solutions; and developing and formulating solutions to specific The company operates in only one segment which is dealing in pharma products.
42GF Score
Get the complete analysis for BOM:544353
PE Ratio (TTM) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:544353 has been successfully added to your 
